CUTR Stock Overview
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cutera, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.15 |
| 52 Week High | US$23.28 |
| 52 Week Low | US$1.28 |
| Beta | 1.67 |
| 1 Month Change | 50.35% |
| 3 Month Change | -17.31% |
| 1 Year Change | -90.06% |
| 3 Year Change | -92.66% |
| 5 Year Change | -88.19% |
| Change since IPO | -84.64% |
Recent News & Updates
Recent updates
Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive
Mar 14
Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be
Aug 11An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued
Apr 19Does Cutera (NASDAQ:CUTR) Have A Healthy Balance Sheet?
Jan 11Would Cutera (NASDAQ:CUTR) Be Better Off With Less Debt?
Oct 06Cutera: Shares Very Attractively Priced, Top-Line Hedged From CMS
Sep 08Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate
Sep 01Cutera: The 'AviClear' Sign To Get Bullish
Jun 22Cutera (NASDAQ:CUTR) Is Carrying A Fair Bit Of Debt
May 27Returns On Capital Signal Tricky Times Ahead For Cutera (NASDAQ:CUTR)
Apr 22Cutera: Gains Aren't Surprising After Acne Laser Therapy Cleared
Mar 31What Does Cutera, Inc.'s (NASDAQ:CUTR) Share Price Indicate?
Feb 23We Think Cutera (NASDAQ:CUTR) Can Stay On Top Of Its Debt
Jan 08Revisiting Cutera
Dec 18We Like These Underlying Return On Capital Trends At Cutera (NASDAQ:CUTR)
Nov 30Is Cutera (NASDAQ:CUTR) A Risky Investment?
Sep 17Shareholder Returns
| CUTR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -9.7% | 1.4% | 1.2% |
| 1Y | -90.1% | -0.7% | 24.7% |
Return vs Industry: CUTR underperformed the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: CUTR underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| CUTR volatility | |
|---|---|
| CUTR Average Weekly Movement | 20.6% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CUTR's share price has been volatile over the past 3 months.
Volatility Over Time: CUTR's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 540 | Taylor Harris | www.cutera.com |
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform.
Cutera, Inc. Fundamentals Summary
| CUTR fundamental statistics | |
|---|---|
| Market cap | US$42.92m |
| Earnings (TTM) | -US$150.83m |
| Revenue (TTM) | US$212.37m |
0.2x
P/S Ratio-0.3x
P/E RatioIs CUTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CUTR income statement (TTM) | |
|---|---|
| Revenue | US$212.37m |
| Cost of Revenue | US$151.35m |
| Gross Profit | US$61.02m |
| Other Expenses | US$211.85m |
| Earnings | -US$150.83m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.56 |
| Gross Margin | 28.73% |
| Net Profit Margin | -71.02% |
| Debt/Equity Ratio | -262.0% |
How did CUTR perform over the long term?
See historical performance and comparison